These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22724032)

  • 1. Immunodominant antigens of Leishmania chagasi associated with protection against human visceral leishmaniasis.
    Abánades DR; Arruda LV; Arruda ES; Pinto JR; Palma MS; Aquino D; Caldas AJ; Soto M; Barral A; Barral-Netto M
    PLoS Negl Trop Dis; 2012; 6(6):e1687. PubMed ID: 22724032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileishmanial IgG and IgE antibodies recognize predominantly carbohydrate epitopes of glycosylated antigens in visceral leishmaniasis.
    Atta AM; Colossi R; Sousa-Atta ML; Jeronimo SM; Nascimento MD; Bezerra GF; Orge G; Carvalho EM
    Mem Inst Oswaldo Cruz; 2004 Aug; 99(5):525-30. PubMed ID: 15543418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an enzyme-linked immunosorbent assay based on crude Leishmania histone proteins for serodiagnosis of human infantile visceral leishmaniasis.
    Lakhal S; Mekki S; Ben-Abda I; Mousli M; Amri F; Aoun K; Bouratbine A
    Clin Vaccine Immunol; 2012 Sep; 19(9):1487-91. PubMed ID: 22815147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi as an antigen for delayed-type hypersensitivity assays and serodiagnosis of canine visceral leishmaniasis.
    Pinheiro PH; Pinheiro AN; Ferreira JH; Costa FA; Katz S; Barbiéri CL
    Vet Parasitol; 2009 May; 162(1-2):32-9. PubMed ID: 19269098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the C-terminal region of 70 kDa heat shock protein from Leishmania (Viannia) braziliensis as a target for the humoral immune response.
    Amorim AG; Carrington M; Miles MA; Barker DC; de Almeida ML
    Cell Stress Chaperones; 1996 Sep; 1(3):177-87. PubMed ID: 9222603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of immunodominant proteins of Leishmania infantum by immunoproteomics to evaluate a recombinant multi-epitope designed antigen for serodiagnosis of human visceral leishmaniasis.
    Heidari S; Hajjaran H; Kazemi B; Gharechahi J; Mohebali M; Ranjbar MM; Akhoundi B; Azarian B; Mirshahvaladi S; Raoofian R
    Exp Parasitol; 2021 Mar; 222():108065. PubMed ID: 33428893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic approach for characterization of immunodominant membrane-associated 30- to 36-kiloDalton fraction antigens of Leishmania infantum promastigotes, reacting with sera from Mediterranean visceral leishmaniasis patients.
    Kamoun-Essghaier S; Guizani I; Strub JM; Van Dorsselaer A; Mabrouk K; Ouelhazi L; Dellagi K
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):310-20. PubMed ID: 15699427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.
    Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL
    Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts.
    Coelho EA; Ramírez L; Costa MA; Coelho VT; Martins VT; Chávez-Fumagalli MA; Oliveira DM; Tavares CA; Bonay P; Nieto CG; Abánades DR; Alonso C; Soto M
    Clin Vaccine Immunol; 2009 Dec; 16(12):1774-80. PubMed ID: 19812259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection.
    White AC; Castes M; Garcia L; Trujillo D; Zambrano L
    Am J Trop Med Hyg; 1992 Feb; 46(2):123-31. PubMed ID: 1539745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of anti-leishmania (Leishmania) chagasi immunoglobulin G by flow cytometry for cure assessment following chemotherapeutic treatment of American visceral leishmaniasis.
    Lemos EM; Gomes IT; Carvalho SF; Rocha RD; Pissinate JF; Martins-Filho OA; Dietze R
    Clin Vaccine Immunol; 2007 May; 14(5):569-76. PubMed ID: 17360851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis.
    Passos S; Carvalho LP; Orge G; Jerônimo SM; Bezerra G; Soto M; Alonso C; Carvalho EM
    Clin Diagn Lab Immunol; 2005 Oct; 12(10):1164-7. PubMed ID: 16210478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Leishmania chagasi immunoglobulin G3 detected by flow cytometry for early cure assessment in American visceral leishmaniasis.
    Gomes IT; Carvalho SF; Rocha RD; Peruhype-Magalhães V; Dietze R; Martins-Filho OA; Lemos EM
    J Immunol Methods; 2010 Aug; 360(1-2):76-83. PubMed ID: 20598707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in northeast Brazil.
    Jeronimo SM; Duggal P; Braz RF; Cheng C; Monteiro GR; Nascimento ET; Martins DR; Karplus TM; Ximenes MF; Oliveira CC; Pinheiro VG; Pereira W; Peralta JM; Sousa J; Medeiros IM; Pearsoni RD; Burns TL; Pugh EW; Wilson ME
    Scand J Infect Dis; 2004; 36(6-7):443-9. PubMed ID: 15307565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping B-cell epitopes for the peroxidoxin of Leishmania (Viannia) braziliensis and its potential for the clinical diagnosis of tegumentary and visceral leishmaniasis.
    Menezes-Souza D; Mendes TA; Nagem RA; Santos TT; Silva AL; Santoro MM; de Carvalho SF; Coelho EA; Bartholomeu DC; Fujiwara RT
    PLoS One; 2014; 9(6):e99216. PubMed ID: 24921246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.
    Boarino A; Scalone A; Gradoni L; Ferroglio E; Vitale F; Zanatta R; Giuffrida MG; Rosati S
    Clin Diagn Lab Immunol; 2005 May; 12(5):647-53. PubMed ID: 15879027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human visceral leishmaniasis: analysis of the specificity of humoral immune response to polypeptides of Leishmania donovani chagasi.
    dos Santos JI; Morgado MG; Galvão-Castro B
    Am J Trop Med Hyg; 1987 Sep; 37(2):263-70. PubMed ID: 2444121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis.
    Pedras MJ; de Gouvêa Viana L; de Oliveira EJ; Rabello A
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):172-8. PubMed ID: 18160087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.
    Bhattacharyya T; Bowes DE; El-Safi S; Sundar S; Falconar AK; Singh OP; Kumar R; Ahmed O; Boelaert M; Miles MA
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2675. PubMed ID: 24587456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL Is highly endemic.
    Zeyrek FY; Korkmaz M; Ozbel Y
    Clin Vaccine Immunol; 2007 Nov; 14(11):1409-15. PubMed ID: 17761525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.